Parkinson's disease Symptoms Before and After Levodopa-Carbidopa Intestinal Gel: a Subanalysis From the COSMOS Study

被引：0
|
作者：
Fasano, A. [1 ]
Toomsoo, T. [2 ]
Hassin-Baer, S.
Van Kesteren, M.
Parra, J. [3 ]
Femia, S.
Chico, S.
Alobaidi, A.
Szasz, J.
机构：
[1] Div Neurol, Toronto, ON, Canada
[2] Dept Neurol, Tallinn, Estonia
[3] AbbVie Inc, N Chicago, IL USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
OPR-150
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [41] Continuous intrajejunal levodopa-carbidopa intestinal gel in the treatment of patients with advanced Parkinson's disease - effects on motor symptoms
    Gmitterova, Karin
    Minar, Michal
    Smutny, Milan
    Valkovic, Peter
    ACTIVITAS NERVOSA SUPERIOR REDIVIVA, 2015, 57 (03): : 57 - 62
  • [42] Continuous intestinal infusion of levodopa-carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous community
    Santos-Garcia, D.
    Catalan, M. J.
    Puente, V
    Valldeoriola, F.
    Regidor, I
    Mir, P.
    Matias-Arbelo, J.
    Parra, J. C.
    Grandas, F.
    NEUROLOGIA, 2021, 36 (02): : 101 - 111
  • [43] Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease
    Meloni, Mario
    Solla, Paolo
    Mascia, Marcello Mario
    Marrosu, Francesco
    Cannas, Antonino
    PARKINSONISM & RELATED DISORDERS, 2017, 37 : 92 - 96
  • [44] Weight variation in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion
    Fernandez-Rodriguez, B.
    Dupouy, J.
    Harroch, E.
    Fabre-Delcros, M. H.
    Barthelemy, C.
    Loubiere, P.
    Barange, K.
    Brefel-Courbon, C.
    Rascol, O.
    Ory-Magne, F.
    MOVEMENT DISORDERS, 2018, 33 : S137 - S137
  • [45] Effect of Levodopa-Carbidopa Intestinal Gel on Resting Tremor in Patients with Advanced Parkinson's Disease
    Fernandez, Hubert
    Dubow, Jordan
    Robieson, Weining
    Chatamra, Krai
    Eaton, Susan
    Benesh, Janet
    Odin, Per
    NEUROLOGY, 2016, 86
  • [46] Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results
    Fernandez, Hubert H.
    Vanagunas, Arvydas
    Odin, Per
    Espay, Alberto J.
    Hauser, Robert A.
    Standaert, David G.
    Chatamra, Krai
    Benesh, Janet
    Pritchett, Yili
    Hass, Steven L.
    Lenz, Robert A.
    PARKINSONISM & RELATED DISORDERS, 2013, 19 (03) : 339 - 345
  • [47] Efficacy of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: Subgroup analyses
    Standaert, D. G.
    Slevin, J. T.
    Espay, A. J.
    Boyd, J. T.
    Fernandez, H. H.
    Pritchett, Y.
    Zhang, W.
    Chatamra, K.
    Widnell, K. L.
    Benesh, J.
    MOVEMENT DISORDERS, 2013, 28 : S143 - S144
  • [48] Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease: A Systematic Review and Meta-Analysis
    Wang, Libo
    Li, Jia
    Chen, Jiajun
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [49] Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson’s disease
    Fernandez H.H.
    Robieson W.Z.
    Chatamra K.
    Dubow J.
    Eaton S.
    Benesh J.A.
    Odin P.
    npj Parkinson's Disease, 2 (1)
  • [50] The Advantages of Levodopa-Carbidopa Intestinal Gel for Patients with Advanced Parkinson's Disease: A Systematic Review
    Zhang, Xing-Ru
    Jiang, Zhi-Yu
    Zhang, Zeng-Rui
    Chen, Hui-Jun
    Wu, Ke
    He, Jin-Cai
    Xie, Cheng-Long
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 845 - 854
12345